Evidence map›Paper›PMID 40549240›Full record

ArticleDiscover oncology2025

A case of angioimmunoblastic T-cell lymphoma mimicking angioedema.

He Zhao, Yun Xia, Fei Su, Liuqing Chen, Bin Hu

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

He Zhao *Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China.
Yun Xia *Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China.
Fei SuDepartment of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China.
Liuqing ChenDepartment of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China. chlq35@126.com.
Bin HuDepartment of Dermatology, Wuhan No. 1 Hospital, Wuhan, 430022, China. binhu88@126.com.

Funding

Hubei Provincial Key Research and Development Projects 2023BCB132Hubei Provincial Natural Science Foundation of China 2025AFB396
6 · The paper itself

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive T-cell lymphoma that accounts for only 1% to 2% of all cases of non-Hodgkin lymphoma (NHL). It usually affects middle-aged to elderly men and is associated with fever, night sweats, weight loss, and lymphadenopathy. Approximately 50% of AITL cases have cutaneous manifestations. However, these are not specific. A middle-aged man presented with facial edema with shortness of breath, which was successively misdiagnosed as oral infection, drug dermatitis, and varicella. The fluctuating and nonspecific manifestations of AITL may complicate and delay the definitive diagnosis, thereby affecting treatment and prognosis. This article summarizes the clinical presentation, pathologic features, differential diagnosis, and treatment of this case, emphasizing the importance of lymph node examination in the development of angioedema.

Indexed as

AngioedemaAngioimmunoblastic T-cell lymphomaNon-Hodgkin lymphomaSkin lesions

Identifiers

PMID40549240
PMCPMC12185804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.